|
Dec 19
|
Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders
|
|
Dec 18
|
Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™
|
|
Nov 2
|
Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company
|
|
Jul 17
|
Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities
|